Ra­dius fal­ters af­ter a PhI­II os­teo­poro­sis fail and a breast can­cer dis­ap­point­ment, send­ing shares plum­met­ing

4 years ago
R&D

Strug­gling Aprea wins a re­prieve as FDA lifts one of the holds on their on­ly drug

4 years ago
R&D

Will ‘orig­i­nal anti­genic sin’ un­der­mine Omi­cron boost­ers? New re­search sug­gests ‘no’

4 years ago
Discovery
Coronavirus

House al­most unan­i­mous­ly pass­es bi­par­ti­san bill to pump $500M in­to ALS drug R&D

4 years ago
R&D

Promis­ing to slim down and speed up, the ‘new’ J&J shakes up the ex­ec­u­tive com­mit­tee ahead of the big split

4 years ago
People
Bioregnum

Fledg­ling Stan­ford spin­out promis­ing 3D mod­els of ful­ly hu­man tis­sue wins the back­ing of some big-time in­vestors

4 years ago
Financing
Cell/Gene Tx

Cin­gu­late prices a down­sized pub­lic of­fer­ing as IPO par­ty ap­pears to die down

4 years ago
Financing

At­las, F-Prime launch K36 Ther­a­peu­tics to ad­vance on­col­o­gy mol­e­cule for elu­sive epi­ge­net­ic tar­get

4 years ago
Financing
Startups

FDA ad­comm votes unan­i­mous­ly against Reata's po­ten­tial Al­port syn­drome treat­ment

4 years ago
R&D
FDA+

Of­fer­ing a long-await­ed op­tion for the un­vac­ci­nat­ed, FDA au­tho­rizes As­traZeneca's long-act­ing pre­ven­ta­tive an­ti­body

4 years ago
FDA+
Coronavirus

Video: Hear from End­points' 2021 Women in Bio­phar­ma R&D hon­orees and lis­ten in on our pan­el dis­cus­sion on break­ing ...

4 years ago
Special

No­var­tis drafts artist No­ma Bar's bold vi­su­als to ex­plain com­plex MDS blood can­cer

4 years ago
Pharma
Marketing

FDA+ roundup: Re­pub­li­cans will be key for Rob Calif­f's con­fir­ma­tion; Janet Wood­cock and Mar­garet Ham­burg talk FDA and ...

4 years ago
FDA+

Omi­cron is a test for the next pan­dem­ic. Will the world keep mak­ing the same mis­takes?

4 years ago
Coronavirus
In Focus

So­tio part­ners with Mer­ck to test lead can­di­date with Keytru­da; DC's KeifeRx rais­es $6M in Se­ries A — and brings on ...

4 years ago
News Briefing

Ex-FDA chief Stephen Hahn lands an­oth­er new gig, this time as CEO of a can­cer test­ing start­up

4 years ago
Financing
FDA+

Biotech up­start gets $50M to test new virus-based ther­a­pies against sol­id tu­mors

4 years ago
Deals
Manufacturing

Mer­ck KGaA's ven­ture arm is ready to make new in­vest­ments, rais­ing more than $675M to get things go­ing

4 years ago
Financing
Pharma

New stud­ies in­di­cate mR­NA vac­cines pro­vide lim­it­ed pro­tec­tion against Omi­cron, but boost­ers and new shots may be ...

4 years ago
R&D
Coronavirus

Ac­cuser fires back at MIT sci­en­tist David Saba­tini's claims he was false­ly ac­cused of sex­u­al ha­rass­ment

4 years ago
People

Phar­ma men­ace Mar­tin Shkre­li's old com­pa­ny to pay up to $40M to states for Dara­prim price goug­ing

4 years ago
Pharma

Vi­vo Cap­i­tal, Bain, Pri­mav­era pour $200M in­to vir­tu­al­ly un­known tar­get­ed on­col­o­gy play out of Chi­na

4 years ago
Financing
China

On the heels of Se­ries A, Nom­ic will join Broad In­sti­tute con­sor­tium and ex­pand ac­cess to plat­form

4 years ago
Manufacturing

New­path Part­ners kicks off $350M fund with a wun­derkind hold­ing the bag and an all-star sci­en­tif­ic team wait­ing in ...

4 years ago
Financing
Startups
First page Previous page 612613614615616617618 Next page Last page
A service from the Financial Times